openPR Logo
Press release

Non-Viral Drug Delivery Systems Market CAGR To Exceed 9.0% by 2035, Due To The Growing Demand For Biologics | Roots Analysis

07-21-2025 03:57 PM CET | Health & Medicine

Press release from: Roots Analysis

Non-Viral Drug Delivery Systems Market CAGR To Exceed 9.0%

According to our latest market report "Non-Viral Drug Delivery Systems Market by Type of Molecule Delivered, Type of Biologic Delivered, Type of Vehicle Used, Target Therapeutic Area, Type of Payment Employed, Key Geographical Regions and Leading Players: Industry Trends and Global Forecasts, till 2035", the global non-viral drug delivery systems market size is projected to reach USD 20.4 billion by 2035 from USD 8.6 billion in the current year, growing at a CAGR of 9.0% in the forecast period.

Non-viral drug delivery systems are at the forefront of innovative technologies for intracellular delivery of biologic drugs which is precise in terms of targeting specific cells. These systems include exosome-based vehicles, cell-penetrating peptides and lipid nanoparticles, that offer significant advantages over viral methods, such as reduced immunogenicity and cytotoxicity. Interestingly, non-viral vectors can transport a diverse range of genetic materials without the size limitations associated with viral vectors which makes non-viral vectors more versatile and cost-effective. As research continues to evolve, non-viral drug delivery systems market is poised to revolutionize therapeutic interventions across a variety of diseases.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market/request-quote.html

Non-Viral Drug Delivery Systems Market Segments

Based on the Type of Molecule Delivered, the market is segmented into biologics and small molecules.

1. The biologics segment is likely to capture the largest revenue share of 95% in the non-viral drug delivery systems market, in the current year.
2. The small molecules segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 14.2% during the forecast period.

Based on the Type of Biologic Delivered, the market is segmented into RNA, DNA, proteins / peptides and antibodies.

1. The RNA segment is likely to capture the largest revenue share of 65% in the non-viral drug delivery systems market, in the current year.
2. The antibodies segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 18.4% during the forecast period.

Based on the Type of Vehicle Used, the market is segmented into nanoparticles, extracellular vesicles, polymers, oligonucleotides and cell penetrating peptides.

1. The nanoparticles segment is likely to capture the largest revenue share of 55% in the non-viral drug delivery systems market, in the current year.
2. The nanoparticles segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 9.7% during the forecast period.

Based on the Target Therapeutic Area, the market is segmented into oncological disorders, infectious diseases, cardiovascular disorders, genetic disorders, hepatic disorders, metabolic disorders, neurological disorders, pulmonary disorders, rare disorders and other disorders.

1. The oncological disorders segment is likely to capture the largest revenue share of ~30% in the non-viral drug delivery systems market, in the current year.
2. The infectious segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 10.7% during the forecast period.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market/request-sample.html

Based on the Type of Payment Employed, the market is segmented into upfront payments and milestone payments.

1. The upfront segment is likely to capture the largest revenue share of ~60% in the non-viral drug delivery systems market, in the current year.
2. The milestone segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 11.5% during the forecast period.

Non-Viral Drug Delivery Systems Market Regional Outlook
Based on the geographical regions, the non-viral drug delivery systems market can be segmented into three major regions, including North America, Europe and Asia-Pacific. North America is anticipated to capture the majority share of the non-viral drug delivery systems market in the current year. Further, the non-viral drug delivery systems in Asia-Pacific is accounted to be the fastest-growing segment of the market. This is primarily due to the rising demand for biologics owing to the growing chronic diseases.

Key Report Takeaways
1. Several key companies (established as well as start-ups) in the non-viral drug delivery systems domain claim to offer drug delivery technologies for delivering various types of molecules, including biologics and small molecules
2. Around 40% of the companies engaged in developing non-viral drug delivery systems are small firms; of these, majority of the firms are based in North America
3. In pursuit of gaining a competitive edge, industry stakeholders are actively innovating and developing novel non-viral drug delivery systems that can be utilized for the treatment of various indications
4. More than 1,140 patents related to non-viral drug delivery systems have been filed / granted by the technology providers in order to protect the intellectual property generated within this field
5. The rising interest in this domain is reflected by the rise in partnership activity; in fact, close to 65% of the deals were inked in the last three years
6. Owing to the numerous advantages offered by non-viral vectors, the non-viral drug delivery systems market is anticipated to grow at an annualized rate of 9.0% in the coming decade
7. The market opportunity is anticipated to be well-distributed across different types of molecule delivered, type of biologics delivered, type of vehicle used, target therapeutic area and key geographies

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html

Non-Viral Drug Delivery Systems Market Companies Profiled
Examples of companies engaged in non-viral drug delivery systems market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Arcturus Therapeutics, Bio-Path Holdings, CureVac, Entos Pharmaceuticals, etherna, Matinas Biopharma, MDimune and PCI Biotech

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Viral Drug Delivery Systems Market CAGR To Exceed 9.0% by 2035, Due To The Growing Demand For Biologics | Roots Analysis here

News-ID: 4112486 • Views:

More Releases from Roots Analysis

Industrial Robotics Market to Reach USD 39.03 Billion by 2035, Driven by Rising Automation Demand Across Manufacturing | Roots Analysis
Industrial Robotics Market to Reach USD 39.03 Billion by 2035, Driven by Rising …
09-04-2025 | Robotics & Automation Press release from: Roots Analysis According to Roots Analysis' latest industry report titled "Industrial Robotics Market: Industry Trends and Global Forecasts, till 2035", the global industrial robotics market is projected to grow from USD 17.64 billion in 2024 to USD 18.80 billion in 2025, reaching USD 39.03 billion by 2035 at a CAGR of 7.5% during the forecast period. To request a quote for this report, visit: https://www.rootsanalysis.com/industrial-robotics-market/request-quote Market Overview Industrial
Targeted Drug Delivery Device Market Size to reach USD 2,153 million by 2035 | Roots Analysis
Targeted Drug Delivery Device Market Size to reach USD 2,153 million by 2035 | R …
According to our latest market report "Targeted Drug Delivery Device Market" by Type of Device, Target Organ, Type of Therapy Delivered, Route of Administration, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the targeted drug delivery device market size is projected to reach USD 2,153 million by 2035 from USD 427 million in 2026, growing at a CAGR of 19.7% in the forecast period, till
The Conjugation and Labeling Services Market is projected to grow at a CAGR of 10.3%, till 2035, claims Roots Analysis
The Conjugation and Labeling Services Market is projected to grow at a CAGR of 1 …
The complexities associated with conjugation of biomolecules and the need for click-chemistry expertise have prompted the pharmaceutical industry to rely on conjugation and labeling service providers To request quote of this report, please visit: https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market/request-quote.html Roots Analysis is pleased to announce the publication of its recent study, titled, "Conjugation and Labeling Services Market, 2023-2035" The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies.
Biologics Contract Manufacturing Market CAGR To Exceed 8.8%, Due To The Growing Demand For Biologics | Roots Analysis
Biologics Contract Manufacturing Market CAGR To Exceed 8.8%, Due To The Growing …
According to our latest market report "Biologics Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035", the global biologics contract manufacturing market size is projected to reach USD 55.0 billion by 2035 from USD USD 23.8 billion in 2025, growing at a CAGR of 8.8% in the

All 5 Releases


More Releases for CAGR

[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends. Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064 According to the report published by Allied Market Research,
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032. This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks
[CAGR of 5.5%] Silica Flour Market Size, CAGR, Competitive Analysis and Forecast …
The global silica flour industry generated $520.0 million in 2021, and is estimated to reach $876.3 million by 2031, witnessing a CAGR of 5.5% from 2022 to 2031. Allied Market Research published a report, titled, "Silica Flour Market by Type (Quartz, Cristobalite), by Application (Fiberglass, Glass and Clay, Oil Well Cement, Ceramic and Refractory, Foundry, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." The report offers a detailed analysis
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial
Call Center AI Market Latest, CAGR, Volume and Value 2022-2030 | (CAGR) of 25%
New York , United States- Report Ocean published the latest research report on the Call Center AI market. In order to comprehend a market holistically, a variety of factors must be evaluated, including demographics, business cycles, and microeconomic requirements that pertain precisely to the market under study. In addition, the Call Center AI market study demonstrates a detailed examination of the business state, which represents creative ways for company growth,